FDA approves first PSMA-targeted radiopharmaceutical
Nat Rev Drug Discov
.
2022 May;21(5):327.
doi: 10.1038/d41573-022-00067-5.
Author
Asher Mullard
PMID:
35396355
DOI:
10.1038/d41573-022-00067-5
No abstract available
Publication types
News
MeSH terms
Humans
Radiopharmaceuticals* / therapeutic use
Substances
Radiopharmaceuticals